Sponsored Content
Sponsored by Sumitomo Pharma America, Inc.
Clinical and Economic Impact of OAB Symptoms in Men Receiving Pharmacological Treatment for BPH
Trending on Managed Healthcare Executive
1
Virtual care replaces, not adds, Medicare visits for health systems, analysis shows
2
FDA approves $2.59 million gene therapy for SMA
3
Optum Rx removes reauthorizations from an additional 40 drugs
4
CMS negotiates a 70% discount for Ozempic and Wegovy
5
